CD4+ CTLs, bearing SLAMF7 on their surface, might be actively involved in the fibrotic processes in IgG4-RD, releasing profibrotic mediators such as IL-1β, TGF-β, and INF-γ [7, 11]. Here, SLAMF7 is linked to immunoglobulin G4-related sclerosing disease.